– November 1, 2010
November 1, 2010
View Issues
-
Newly Diagnosed CML
A 64-year-old man was referred because of leukocytosis. He had been in his usual state of health until approximately two months prior to a visit, when he was diagnosed by his primary care provider with pneumonia. -
Have We Moved Beyond the Karnofsky Score?
Extensive literature is developing on the role of functional assessment of cancer patients, particularly those who are elderly, in order to provide safer and more effective treatment. -
Statins and PSA Recurrence Post-radical Prostatectomy
Drugs in the statin class have clearly demonstrated clinical benefit, particularly in lowering cholesterol and reducing cardiovascular mortality. -
Determining the Importance of Careful Follow-up for Patients with MGUS
The benefit of regular follow-up for monoclonal gammopathy of unknown significance (MGUS) to detect progression to multiple myeloma (MM) remains unknown. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.